UNITY
is a biotechnology company that develops and commercializes novel therapeutics for the treatment of aging-related diseases... Read moreUNITY
is a biotechnology company that develops and commercializes novel therapeutics for the treatment of aging-related diseases... Read more
News
Mar 25, 2025
Clinical Trials Arena
UNITY: Unity reports topline outcomes from trial of diabetic macular oedema therapy
Mar 25, 2025
BioSpace
UNITY: Opthea, UNITY Fail to Unseat Regeneron's Eylea in Vision Disorders
Mar 25, 2025
Zacks
UNITY: UBX Stock Down 29% on Mixed Results From Phase II Eye Disease Study
Mar 24, 2025
RTTNews
UNITY: Unity Biotechnology's Phase 2b Study Misses Primary Analysis Endpoint, Stock Falls In Pre-Market
Mar 24, 2025
Eyewire News
UNITY: Unity Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in DME
Mar 24, 2025
Seeking Alpha
UNITY: UNITY Biotechnology tanks after failing to meet goal in eye disorder treatment trial
Mar 24, 2025
Benzinga
UNITY: Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls
Mar 24, 2025
Benzinga
UNITY: Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls
Mar 10, 2025
Owler
UNITY Biotechnology, Inc.: UNITY's employee count changed from 19 in Dec 2023 to 16 in Dec 2024
Mar 07, 2025
centralcharts
Press Release: UNITY : UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
UNITY Competitors
1
2
3
4
5